Healius Limited ( (AU:HLS) ) just unveiled an update.
Healius Limited has announced changes to the employment terms of its CEO, Paul Anderson, transitioning his role to permanent ongoing employment and increasing his fixed annual remuneration. The CEO’s incentive arrangements for FY27 will align with other key management personnel, including short-term and long-term incentives, reflecting a strategic move to enhance leadership stability and align executive compensation with company performance goals.
More about Healius Limited
Healius Limited is a leading healthcare company in Australia, dedicated to providing quality, affordable, and accessible healthcare services. The company operates two main diagnostics businesses: pathology and imaging, offering specialty diagnostic services across Australia through a network of centers and over 10,500 employees.
YTD Price Performance: -6.13%
Average Trading Volume: 1,194
Technical Sentiment Signal: Strong Buy
Current Market Cap: €568.4M
For a thorough assessment of HLS stock, go to TipRanks’ Stock Analysis page.
